Skip to main content

Table 2 Sample characteristics according to the types of cancer

From: Factors associated with malnutrition in hospitalized cancer patients: a croos-sectional study

  

Type of cancer

Characteristics

Total sample

UGITa

LGITb

RSc

Lung

Breast

Othersd

Type of cancer - n (%)

277 (100)

43 (15.5)

58 (20.9)

52 (18.8)

32 (11.6)

30 (10.8)

62 (22.4)

Age - Mean (SD)

54.7 (14.9)

57.6(13.3)

57.6 (12.9)

52.9 (15.3)

57.7 (13.8)

56.6 (15.5)

48.8 (16.2)

 ≥60 - n (%)

109 (39.4)

20 (18.3)

29 (26.6)

19 (17.4)

13 (11.9)

12 (11.0)

16 (14.7)

Gender - n (%)

 Male

122 (44.0)

23 (18.9)

20 (16.4)

15 (12.3)

21 (17.2)

0 (0.0)

43 (35.2)

 Female

155 (56.0)

20 (12.9)

38 (24.5)

37 (23.9)

11 (7.1)

30 (19.4)

19 (12.3)

Metastasis - n (%)

 Absent

138 (49.8)

15 (10.9)

29 (21.0)

26 (18.8)

11 (8.0)

19 (13.8)

38 (27.5)

 Present

139 (50.2)

28 (20.1)

29 (20.9)

26 (18.7)

21 (15.1)

11 (7.9)

24 (17.3)

Performance status - n (%)

 <2

149 (53.8)

20 (13.4)

36 (24.2)

23 (15.4)

14 (9.4)

17 (11.4)

39 (26.2)

 ≥2

128 (46.2)

23 (18.0)

22 (17.2)

29 (22.7)

18 (14.1)

13 (10.2)

23 (18.0)

Symptoms of impact - n (%)

 Yes

186 (67.1)

31 (16.7)

35 (18.8)

39 (21.0)

26 (14.0)

17 (9.1)

38 (20.4)

 No

91 (32.9)

12 (13.2)

23 (25.3)

13 (14.3)

6 (6.6)

13 (14.3)

24 (26.4)

%WL ≥5 em 6 meses - n (%)

 Yes

101 (80.2)

20 (19.8)

21 (20.8)

15 (14.9)

15 (14.9)

5 (5.0)

25 (24.8)

 No

25 (19.8)

2 (8.0)

5 (20.0)

7 (28.0)

1 (4.0)

4 (16.0)

6 (24.0)

Overweight (pBMI) - n (%)

 Yes

76 (60.3)

14 (18.4)

12 (15.8)

15 (19.7)

12 (15.8)

4 (5.3)

19 (25.0)

 No

50 (39.7)

8 (16.0)

14 (28.0)

7 (14.0)

4 (8.0)

5 (10.0)

12 (24.0)

PG-SGA - n (%)

 Well nourished

80 (28.9)

7 (8.8)

19 (23.8)

13 (16.3)

5 (6.3)

13 (16.3)

23 (28.8)

 Moderate malnutrition

98 (35.4)

8 (8.2)

21 (21.4)

21 (21.4)

17 (17.3)

12 (12.2)

19 (19.4)

 Severe malnutrition

99 (35.7)

28 (28.3)

18 (18.2)

18 (18.2)

10 (10.1)

5 (5.1)

20 (20.2)

  1. SD standard deviation, PS performance status, %WL weight loss percentage, PG-SGA patient-generated subjective global assessment; aUpper gastrointestinal tract: esophagus, stomach, pancreas, liver, gallbladder, biliary ducts; bLower gastrointestinal tract: colon, rectum and anal canal; cReproductive system: ovarian, cervical, testicular and prostate; dHead and neck, hematological, unknown primary site, sarcoma, melanoma